STRS Ohio’s Cidara Therapeutics CDTX Stock Holding History

STRS Ohio’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,500	Closed	-$773K	–	2142
2025 Q4	$773K	Buy	+3,500	New	+$566K	﹤0.01%	805
2021 Q2	–	Sell	-1,550	Closed	-$82K	–	2257
2021 Q1	$82K	Hold	1,550	–	–	﹤0.01%	1975
2020 Q4	$62K	Hold	1,550	–	–	﹤0.01%	1968
2020 Q3	$88K	Buy	1,550 +730	+89%	+$51.6K	﹤0.01%	1866
2020 Q2	$60K	Buy	+820	New	+$53.1K	﹤0.01%	1878
2017 Q2	–	Sell	-290	Closed	-$45K	–	1942
2017 Q1	$45K	Hold	290	–	–	﹤0.01%	1785
2016 Q4	$60K	Hold	290	–	–	﹤0.01%	1761
2016 Q3	$66K	Sell	290 -10	-3%	-$2.31K	﹤0.01%	1728
2016 Q2	$61K	Buy	300 +225	+300%	+$54.5K	﹤0.01%	1740
2016 Q1	$19K	Hold	75	–	–	﹤0.01%	1824
2015 Q4	$25K	Hold	75	–	–	﹤0.01%	1835
2015 Q3	$19K	Hold	75	–	–	﹤0.01%	1825
2015 Q2	$21K	Buy	+75	New	+$23.1K	﹤0.01%	1813

STRS Ohio's CDTX Position: Q1 2026 in Review

STRS Ohio sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 3,500 shares — an estimated $773K sold.

STRS Ohio first reported a position in CDTX in Q2 2015 and held it in 13 quarters. The position peaked at $773K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

STRS Ohio reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
STRS Ohio sold 3,500 Cidara Therapeutics shares in Q1 2026, an estimated $773K.
STRS Ohio first reported a position in Cidara Therapeutics in Q2 2015 and held it in 13 quarters.
STRS Ohio's Cidara Therapeutics position peaked at $773K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.